Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies

Helen Dolk(University of Ulster), Lolkje T. W. de Jong-van den Berg, Maria Loane(University of Ulster), Diana Wellesley(University Hospital Southampton NHS Foundation Trust), Bérénice Doray(Hôpital d'Hautepierre), Marian K. Bakker(University Medical Center Groningen), Joan K. Morris(St George's, University of London), David Tucker(UNSW Sydney), Karin Källén(Lund University), Anna Latos‐Bieleńska(Poznan University of Medical Sciences), Anna‐Maria Lahesmaa‐Korpinen(University of Helsinki), Ester Garne(University of Southern Denmark), Hao Wang(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), Kari Klungsøyr(Norwegian Institute of Public Health), Vera Nelen(Provincial Institute for Hygiene), Anna Pierini(Istituto di Fisiologia Clinica), Babak Khoshnood(Inserm), Larraitz Arriola(Basque Government), Mary O’Mahony(Health Service Executive), Jan P. Mejnartowicz(University of Ulster), Ingeborg Barišić(University of Zagreb), Miriam Gatt(Ministry for Health), Amanda J. Neville(University of Ferrara), Anke Rißmann(Otto-von-Guericke-Universität Magdeburg), Marie‐Claude Addor(University Hospital of Lausanne), Awi Wiesel(Johannes Gutenberg University Mainz)

University of Southern Denmark Research Portal (University of Southern Denmark)

July 1, 2016

Cited by 0

|New England Journal of Medicine|2013|1k

|The American Journal of Medicine|2009|941

|The Lancet|2013|557

|American Journal of Clinical Nutrition|2015|360

|Transplantation|2002|326

Related Papers